Niazi T, Nabid A, Malagon T, Bettahar R, et al. Hypofractionated, Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the safety analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ led phase III trial. Int J Radiat Oncol Biol Phys 2023 May 22:S0360-3016(23)00459.
PMID: 37224928